Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company’s weight loss obesity shot CagriSema, which delivered less weight...
Novo Nordisk says more than 246000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s … source
US equity futures take a breather from a global rout driven by stocks sensitive to potential disruption from Anthropic’s new automation tool. Investors await results from...
Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend...
Novo Nordisk’s weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years after Wegovy’s US launch, the Danish drugmaker’s...
Get a jump start on the US trading day with Matt Miller, Katie Greifeld and Sonali Basak on “Bloomberg Open Interest.” Union Pacific will buy Norfolk...
After years of high demand and prices, Novo Nordisk announced it is lowering the out-of-pocket cost of its weight loss drug Wegovy. Some experts say it...
Aug.05 — Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish … source
Bloomberg’s Joe Easton has a rundown of the stocks to keep an eye on today, including pharmaceutical firms Novartis, Novo Nordisk and GSK, Spanish bank BBVA,...
“The Pulse With Francine Lacqua” is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in...
On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.